Pancreas Transplant Outcomes

At a Glance

• First transplant: 05/11/87
• Transplants performed in 2020: 3
• Total number of program transplants through 2020: 170
• Received Medicare approval: 07/01/99

Outcomes

• Pre-transplant mortality#: .00 (expected .025, national .05)
  

Adult one- and three-year patient survival rates for PAK (pancreas after kidney transplant)*:

• Henry Ford one-year patient survival rate: 100.00%
• Henry Ford one-year expected patient survival rate^: 95.17%

• Henry Ford three-year patient survival rate: 66.66%
• Henry Ford three-year expected patient survival rate^: 93.41%

Adult one- and three-year patient survival rates for PTA (pancreas transplant alone)*

• Henry Ford one-year patient survival rate: 100.00%
• Henry Ford one-year expected patient survival rate^: 100.00%

• Henry Ford three-year patient survival rate^: 0%
• Henry Ford three-year patient survival rate^: 98.28%

# Patients on the waitlist between 01/01/2020 – 03/12/2020 and 06/13/2020 – 12/31/2021

*Estimated probability of surviving at one year, for patients receiving their first transplant between 01/01/2019 -03/12/2020 and 06/13/2020 – 06/30/2021; and at three years between for patients receiving their first transplant between 07/01/2016 and 12/31/2018
^ Adjusted for patient and donor characteristics

Source: Scientific Registry of Transplant Recipients, Center and OPO-specific Reports, based on data available April 30, 2022, released July 6, 2022.